United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news Neustar to acquire authentication and fraud solution firm TRUSTID Neustar acquisition of TRUSTID : Neustar, a real-time information and analytics provider, has agreed to acquire Oregon-based authentication… bySoujanya RaviDecember 15, 2018
